Drug Toxicology and Safety Pharmacology

MSc Full-time

Suitable for International Students?

Yes

Course Introduction

Before any new therapy can be used, a thorough identification of its toxicity and safety is required. Therefore, drug toxicology and safety pharmacology are central to the chemical and pharmaceutical industries, and demand for 'pre-trained' employees is extremely high.

Hosted by the Institute of Cancer Therapeutics, the course addresses key aspects of preclinical drug evaluation through the study of drug discovery and development; safety pharmacology; mechanisms of drug-induced toxicities; regulatory affairs and bioanalytical sciences.

It will provide you with state-of-the-art training in the area of preclinical toxicology with an emphasis on the molecular and in vivo aspects of toxicological assessment.

It is designed for individuals with a first degree in a scientific disciple who want to specialise in new medicines development or undertake employment in the pharmaceutical industry.

Course Syllabus

2011/12: All Modules are Core

Semester 1 (60 Credits - 4 Modules):

• Critical Appraisal of a Current Topic in Safety Pharmacology (20 Credits split over both Semesters, 10 Credits per Semester)
• Preclinical Models for Drug Evaluation (20 Credits)
• Research and Analytical Methods in Safety Pharmacology (20 Credits split over both Semesters, 10 Credits per Semester)
• Toxicology and Safety Pharmacology (20 Credits)

Semester 2 (60 Credits - 4 Modules):

• Critical Appraisal of a Current Topic in Safety Pharmacology (20 Credits split over both Semesters, 10 Credits per Semester)
• Experimental Design for Safety Pharmacology (20 Credits)
• Molecular Mechanisms of Toxicity (20 Credits)
• Research and Analytical Methods in Safety Pharmacology (20 Credits split over both Semesters, 10 Credits per Semester)

End of Semester 2 onwards (60 Credits - 1 Module):

• Research Project (Safety Pharmacology) (60 Credits)